综述

脂质代谢昼夜节律机制及其对脑卒中发病的影响综述

  • 李北 ,
  • 李婧晨 ,
  • 郭熙朗 ,
  • 於原思渡 ,
  • 罗亦弘 ,
  • 胡琴 ,
  • 高丽
展开
  • 1.上海交通大学医学院附属仁济医院神经内科,上海 200127
    2.上海交通大学医学院仁济临床医学院,上海 200127
    3.上海交通大学医学院附属仁济医院神经外科,上海 200127
高 丽,副主任医师,博士;电子信箱:gaoli246619@126.com
胡 琴,研究员,博士;电子信箱:huqinle20010709@126.com

收稿日期: 2025-12-20

  录用日期: 2026-02-02

  网络出版日期: 2026-05-28

基金资助

上海交通大学“交大之星”医工交叉项目(YG2023QNB10);上海交通大学医学院大学生创新训练计划(20260241);仁济医院国自然推进项目(RJTJ26-MS-017)

Review of circadian rhythm mechanism of lipid metabolism and its impact on the incidence of stroke

  • Li Bei ,
  • Li Jingchen ,
  • Guo Xilang ,
  • Yu Yuansidu ,
  • Luo Yihong ,
  • Hu Qin ,
  • Gao Li
Expand
  • 1.Department of Neurology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
    2.Renji Clinical Medical College, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
    3.Department of Neurosurgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
Gao Li, E-mail: gaoli246619@126.com
Hu Qin, E-mail: huqinle20010709@126.com.

Received date: 2025-12-20

  Accepted date: 2026-02-02

  Online published: 2026-05-28

Supported by

Fundamental Research Funds for the Central Universities(YG2023QNB10);Innovative Training Program for College Students of Shanghai Jiao Tong University School of Medicine(20260241);National Natural Science Foundation of China Promotion Project of Renji Hospital, Shanghai Jiao Tong University School of Medicine(RJTJ26-MS-017)

摘要

脑卒中作为一种以局灶性或全脑功能损害为核心临床特征的脑血管病,具有高发病率、高致残率与高死亡率的特征,其发病具有一定的昼夜节律性。随着现代生活节奏加快以及科技的发展,夜班工作、跨时区出行增多,同时电子产品使用时长与娱乐时间的延长,致使昼夜节律紊乱的人群增加。已有研究证实,昼夜节律紊乱与代谢综合征、心脑血管疾病等多种疾病的发病风险显著相关,但其具体机制尚未明晰。脂质代谢异常是脑卒中,特别是缺血性脑卒中发病的重要危险因素。机体内脂质的消化、吸收、运输、合成、分解及氧化过程,均受到中枢和外周分子钟的精确调控,呈现出显著的时序特征。昼夜节律紊乱与脂质代谢异常、动脉粥样硬化密切相关。该文对昼夜节律调控脂质代谢的机制,及其在脑卒中发病与进展中的作用进行综述,并基于此提出脑卒中“时间疗法”的新策略。

本文引用格式

李北 , 李婧晨 , 郭熙朗 , 於原思渡 , 罗亦弘 , 胡琴 , 高丽 . 脂质代谢昼夜节律机制及其对脑卒中发病的影响综述[J]. 上海交通大学学报(医学版), 2026 , 46(5) : 672 -679 . DOI: 10.3969/j.issn.1674-8115.2026.05.014

Abstract

Stroke, a cerebrovascular disease characterized by focal or global brain function impairment as its core clinical feature, is associated with high incidence, disability, and mortality rates. Its onset exhibits a certain circadian rhythmicity. With the acceleration of modern life rhythms and the development of science and technology, the prevalence of night-shift work and cross-time-zone travel has increased. Meanwhile, prolonged use of electronic products and extended entertainment time have led to an increase in the number of people with circadian rhythm disorders. Existing studies have confirmed that circadian rhythm disorders are significantly associated with the risk of various diseases, such as metabolic syndrome and cardiovascular and cerebrovascular diseases. However, the specific mechanisms remain unclear. Abnormal lipid metabolism is an important risk factor for stroke, especially ischemic stroke. The processes of lipid digestion, absorption, transport, synthesis, decomposition, and oxidation in the body are precisely regulated by central and peripheral molecular clocks, showing significant temporal characteristics. Circadian rhythm disorders are closely related to abnormal lipid metabolism and atherosclerosis. This article reviews the mechanisms by which circadian rhythms regulate lipid metabolism and their role in the onset and progression of stroke, and based on this, proposes new targets for stroke chronotherapy.

参考文献

[1] Feigin V L, Stark B, Johnson C O, et al. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet Neurol, 2021, 20(10): 795-820.
[2] Ripamonti L, Riva R, Maioli F, et al. Daily variation in the occurrence of different subtypes of stroke[J]. Stroke Res Treat, 2017, 2017: 9091250.
[3] Ramsey A M, Stowie A, Castanon-Cervantes O, et al. Environmental circadian disruption increases stroke severity and dysregulates immune response[J]. J Biol Rhythms, 2020, 35(4): 368-376.
[4] Stenvers D J, Scheer F A J L, Schrauwen P, et al. Circadian clocks and insulin resistance[J]. Nat Rev Endocrinol, 2019, 15(2): 75-89.
[5] Xiao Y, Li Y, Gu J N, et al. Circadian rhythm gene cryptochrome 2 (Cry2) interacts with lipid metabolism to promote vascular aging[J]. Arch Gerontol Geriatr, 2025, 131: 105761.
[6] Gooley J J, Chua E C. Diurnal regulation of lipid metabolism and applications of circadian lipidomics[J]. J Genet Genomics, 2014, 41(5): 231-250.
[7] Petrenko V, Sinturel F, Riezman H, et al. Lipid metabolism around the body clocks[J]. Prog Lipid Res, 2023, 91: 101235.
[8] Sinturel F, Spaleniak W, Dibner C. Circadian rhythm of lipid metabolism[J]. Biochem Soc Trans, 2022, 50(3): 1191-1204.
[9] Fodor D M, Marta M M, Perju-Dumbrav? L. Implications of circadian rhythm in stroke occurrence: certainties and possibilities[J]. Brain Sci, 2021, 11(7): 865.
[10] Reidler P, Brehm A, Sporns P B, et al. Circadian rhythm of ischaemic core progression in human stroke[J]. J Neurol Neurosurg Psychiatry, 2023, 94(1): 70-73.
[11] Ryu W S, Hong K S, Jeong S W, et al. Association of ischemic stroke onset time with presenting severity, acute progression, and long-term outcome: a cohort study[J]. PLoS Med, 2022, 19(2): e1003910.
[12] Webb A J S, Klerman E B, Mandeville E T. Circadian and diurnal regulation of cerebral blood flow[J]. Circ Res, 2024, 134(6): 695-710.
[13] Kamat P K, Khan M B, Smith C, et al. The time dimension to stroke: circadian effects on stroke outcomes and mechanisms[J]. Neurochem Int, 2023, 162: 105457.
[14] Gu F Y, Klerman E B, Kim S, et al. Diurnal variation of metabolites in three individual participants[J]. Chronobiol Int, 2019, 36(3): 332-342.
[15] Pan X, Hussain M M. Diurnal regulation of microsomal triglyceride transfer protein and plasma lipid levels[J]. J Biol Chem, 2007, 282(34): 24707-24719.
[16] Minami Y, Kasukawa T, Kakazu Y, et al. Measurement of internal body time by blood metabolomics[J]. Proc Natl Acad Sci U S A, 2009, 106(24): 9890-9895.
[17] Hayashi T, Ai M, Goto S, et al. Circadian rhythm of subspecies of low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol in healthy subjects and patients with type 2 diabetes[J]. J Atheroscler Thromb, 2023, 30(1): 3-14.
[18] Escobar C, Díaz-Mu?oz M, Encinas F, et al. Persistence of metabolic rhythmicity during fasting and its entrainment by restricted feeding schedules in rats[J]. Am J Physiol, 1998, 274(5): R1309-R1316.
[19] Balakrishnan A, Tavakkolizadeh A, Rhoads D B. Circadian clock genes and implications for intestinal nutrient uptake[J]. J Nutr Biochem, 2012, 23(5): 417-422.
[20] Yu F J, Wang Z G, Zhang T P, et al. Deficiency of intestinal Bmal1 prevents obesity induced by high-fat feeding[J]. Nat Commun, 2021, 12: 5323.
[21] Shapiro D J, Rodwell V W. Diurnal variation and cholesterol regulation of hepatic HMG-CoA reductase activity[J]. Biochem Biophys Res Commun, 1969, 37(5): 867-872.
[22] G?lman C, Angelin B, Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis[J]. Gastroenterology, 2005, 129(5): 1445-1453.
[23] Adamovich Y, Rousso-Noori L, Zwighaft Z, et al. Circadian clocks and feeding time regulate the oscillations and levels of hepatic triglycerides[J]. Cell Metab, 2014, 19(2): 319-330.
[24] Sahar S, Masubuchi S, Eckel-Mahan K, et al. Circadian control of fatty acid elongation by SIRT1 protein-mediated deacetylation of acetyl-coenzyme A synthetase 1[J]. J Biol Chem, 2014, 289(9): 6091-6097.
[25] Manoogian E N, Panda S. Circadian clock, nutrient quality, and eating pattern tune diurnal rhythms in the mitochondrial proteome[J]. Proc Natl Acad Sci U S A, 2016, 113(12): 3127-3129.
[26] Pan X, O'Hare J, Mowdawalla C, et al. Bmal1 is involved in the regulation of macrophage cholesterol homeostasis[J]. JCI Insight, 2025, 10(21): e194304.
[27] Hussain M M, Pan X Y. Circadian regulators of intestinal lipid absorption[J]. J Lipid Res, 2015, 56(4): 761-770.
[28] Gooley J J. Circadian regulation of lipid metabolism[J]. Proc Nutr Soc, 2016, 75(4): 440-450.
[29] Pan X Y, Mota S, Zhang B Y. Circadian clock regulation on lipid metabolism and metabolic diseases[J]. Adv Exp Med Biol, 2020, 1276: 53-66.
[30] Lo E H, Albers G W, Dichgans M, et al. Circadian biology and stroke[J]. Stroke, 2021, 52(6): 2180-2190.
[31] Li X H, He Y J, Wang D W, et al. Chronobiological disruptions: unravelling the interplay of shift work, circadian rhythms, and vascular health in the context of stroke risk[J]. Clin Exp Med, 2024, 25(1): 6.
[32] Gaggini M, Gorini F, Vassalle C. Lipids in atherosclerosis: pathophysiology and the role of calculated lipid indices in assessing cardiovascular risk in patients with hyperlipidemia[J]. Int J Mol Sci, 2022, 24(1): 75.
[33] Cho H, Zhao X, Hatori M, et al. Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β[J]. Nature, 2012, 485(7396): 123-127.
[34] Man A W C, Li H G, Xia N. Circadian rhythm: potential therapeutic target for atherosclerosis and thrombosis[J]. Int J Mol Sci, 2021, 22(2): 676.
[35] Jahdkaran M, Sistanizad M. From lipids to glucose: investigating the role of dyslipidemia in the risk of insulin resistance[J]. J Steroid Biochem Mol Biol, 2025, 250: 106744.
[36] Tran H T, Kondo T, Ashry A, et al. Effect of circadian clock disruption on type 2 diabetes[J]. Front Physiol, 2024, 15: 1435848.
[37] D?browska E, Narkiewicz K. Hypertension and dyslipidemia: the two partners in endothelium-related crime[J]. Curr Atheroscler Rep, 2023, 25(9): 605-612.
[38] Akhtar N, Al-Jerdi S, Kamran S, et al. Night-time non-dipping blood pressure and heart rate: an association with the risk of silent small vessel disease in patients presenting with acute ischemic stroke[J]. Front Neurol, 2021, 12: 719311.
[39] Zhou X, Gu Y Q, Li L. Oxidative stress and inflammatory response in cerebral infarction due to hyperlipidemia and lipid-lowering, anti-inflammatory, and antioxidant therapy[J]. J Neurol Sci, 2025, 476: 123620.
[40] Kim J H, Choi K H, Kang K W, et al. Impact of visceral adipose tissue on clinical outcomes after acute ischemic stroke[J]. Stroke, 2019, 50(2): 448-454.
[41] Cardinali D P, Brown G M, Pandi-Perumal S R. Handbook of clinical neurology (vol. 179)[M]. Amsterdam: Elsevier, 2021.
[42] Saposnik G, Fonarow G C, Pan W, et al. Guideline-directed low-density lipoprotein management in high-risk patients with ischemic stroke: findings from Get with the Guidelines-Stroke 2003 to 2012[J]. Stroke, 2014, 45(11): 3343-3351.
[43] Amarenco P, Lavallée P, Touboul P J. Stroke prevention, blood cholesterol, and statins[J]. Lancet Neurol, 2004, 3(5): 271-278.
[44] Vujovi? N, Piron M J, Qian J Y, et al. Late isocaloric eating increases hunger, decreases energy expenditure, and modifies metabolic pathways in adults with overweight and obesity[J]. Cell Metab, 2022, 34(10): 1486-1498.e7.
[45] Liu L L, Chen W, Wu D, et al. Metabolic efficacy of time-restricted eating in adults: a systematic review and meta-analysis of randomized controlled trials[J]. J Clin Endocrinol Metab, 2022, 107(12): 3428-3441.
[46] Wang C, Quan Y W, Wang L F, et al. Effect of timing of administration on lipid-lowering efficacy of statins-meta-analysis[J]. Eur J Clin Pharmacol, 2023, 79(12): 1641-1656.
[47] Minami M, Kimura S, Endo T, et al. Effects of dietary docosahexaenoic acid on survival time and stroke-related behavior in stroke-prone spontaneously hypertensive rats[J]. Gen Pharmacol, 1997, 29(3): 401-407.
[48] Vilas D, Gomis M, Blanco M, et al. Circadian rhythms in the efficacy of intravenous alteplase in patients with acute ischemic stroke and middle cerebral artery occlusion[J]. Chronobiol Int, 2012, 29(10): 1383-1389.
[49] Mergenthaler P, Balami J S, Neuhaus A A, et al. Stroke in the time of circadian medicine[J]. Circ Res, 2024, 134(6): 770-790.
文章导航

/